Stewart CE, Rotwein P: Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev. 1996, 76 (4): 1005-1026.
Lee PDK, Giudice LC, Conover CA, Powell DR: IGFBP-1: Recent findings and new directions. Proc Soc Exp Biol Med. 1997, 216: 319-357.
Frystyk J, Orskov H: IGF-I, IGF-II, IGF-binding proteins and Diabetes. International Textbook of Diabetes Mellitus. Edited by: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H. 1997, 1: 417-436. John Wiley and Sons Ltd, 2
Lewitt MS, Denyer GS, Cooney GJ, Baxter RC: Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology. 1991, 129 (4): 2254-2256.
Crossey PA, Jones JS, Miell JP: Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes. 2000, 49 (3): 457-465.
Busby WH, Snyder DK, Clemmons DR: Radioimmunoassay of a 26, 000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. J Clin Endocrinol Metab. 1988, 67 (6): 1225-1230.
Straus DS, Ooi GT, Orlowski CC, Rechler MM: Expression of the genes for insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding proteins-1 and -2 in fetal rat under conditions of intrauterine growth retardation caused by maternal fasting. Endocrinology. 1991, 128 (1): 518-525.
Bereket A, Lang CH, Wilson TA: Alterations in the growth hormone-IGF axis in insulin dependent diabetes mellitus. Horm Metab Res. 1999, 31: 172-181.
Ooi GK, Brown DR, Suh D-S, Tseng LY-H, Rechler MM: Cycloheximide stabilises IGFBP-1 mRNA and inhibits IGFBP-1 transcription in H4IIE cells. J Biol Chem. 1993, 268: 16664-16672.
Patel S, Lochhead PA, Rena G, Fumagalli S, Pende M, Kozma S, Thomas GM, Sutherland C: Insulin regulation of IGF-binding protein-1 gene expression is dependent on mammalian target of rapamycin (mTOR), but independent of S6K activity. J Biol Chem. 2002, 277 (12): 9889-9895. 10.1074/jbc.M109870200
Avruch J: Insulin signal transduction through protein kinase cascades. Mol Cell Biochem. 1998, 182: 31-48. 10.1023/A:1006823109415
Leslie NR, Biondi RM, Alessi DR: Pi-regulated kinases and PI phosphatases. Chem Rev. 2001, 101 (8): 2365-2380. 10.1021/cr000091i
Sutherland C, Leighton IA, Cohen P: Inactivation of glycogen synthase kinase-3β by phosphorylation; new kinase connections in insulin and growth factor signalling. Biochem J. 1993, 296: 15-19.
Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of GSK3 by insulin mediated by protein kinase B. Nature. 1995, 378: 785-789. 10.1038/378785a0
Welsh GI, Miller CM, Loughlin AJ, Price NT, Proud CG: Regulation of eIF2B: GSK3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett. 1998, 421 (2): 125-130. 10.1016/S0014-5793(97)01548-2
Cichy SB, Uddin S, Danilkovitch A, Guo S, Klippel A, Unterman TG: PKB mediates effects of insulin on hepatic IGFBP1 gene expression through a conserved insulin response sequence. J Biol Chem. 1998, 273 (11): 6482-6487. 10.1074/jbc.273.11.6482
O'Brien RM, Granner DK: Regulation of gene expression by insulin. Physiol Rev. 1996, 76: 1109-1161.
Vander Kooi BT, Streeper RS, Svitek CA, Oeser JK, Powell DR, O'Brien RM: The Three insulin response sequences in the glucose-6-phosphatase catalytic subunit gene promoter are functionally distinct. J Biol Chem. 2003, 278 (14): 11782-11793. 10.1074/jbc.M212570200
Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D: Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 2003, 423 (6939): 550-555. 10.1038/nature01667
Sutherland C, O'Brien RM, Granner DK: Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of Phosphoenolpyruvate Carboxykinase gene expression by insulin. J Biol Chem. 1995, 270 (26): 15501-15506. 10.1074/jbc.270.26.15501
Dickens M, Svitek CA, Culbert AA, O'Brien RM, Tavare JM: Central Role for PI 3-kinase in the repression of glucose-6-phosphatase gene transcription by insulin. J Biol Chem. 1998, 273: 20144-20149. 10.1074/jbc.273.32.20144
Guo S, Rena G, Cichy S, He X, Cohen P, Unterman TG: Phosphorylation of Ser 256 by PKB disrupts transactivation by FKHR and mediates effects of insulin on IGFBP-1 promoter activity through a conserved insulin response sequence. J Biol Chem. 1999, 274 (24): 17184-17192. 10.1074/jbc.274.24.17184
Rena G, Prescott AR, Guo S, Cohen P, Unterman TG: Roles of the forkhead in rhabdomyosarcoma (FKHR)phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting. Biochem J. 2001, 354: 605-612. 10.1042/0264-6021:3540605
Rena G, Woods YL, Prescott AR, Peggie M, Unterman TG, Williams MR, Cohen P: Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J. 2002, 21 (9): 2263-2271. 10.1093/emboj/21.9.2263
Band CJ, Posner BI: PI 3-kinase and p70S6 kinase are required for insulin but not bisperoxovanadium 1, 10-phenanthroline inhibition of IGFBP gene expression. J Biol Chem. 1997, 272 (1): 138-145. 10.1074/jbc.272.1.138
Patel S, Lochhead PA, Rena G, Sutherland C: Antagonistic effects of phorbol esters on insulin regulation of IGFBP-1 but not glucose-6-phosphatase gene expression. Biochem J. 2001, 359 (3): 611-619. 10.1042/0264-6021:3590611
Patel S, Lipina C, Sutherland C: Different mechanisms are used by insulin to repress three genes that contain a homologous thymine-rich insulin response element. FEBS Lett. 2003, 549: 72-76. 10.1016/S0014-5793(03)00774-9
Lochhead PA, Coghlan MP, Rice SQJ, Sutherland C: Inhibition of GSK3 selectively reduces G6Pase and PEPCK gene expression. Diabetes. 2001, 50: 937-947.
Coghlan MP, Culbert AA, Cross DAE, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Cox LR: Selective small molecule inhibitors of GSK-3 modulate glycogen metabolism and gene transcription. Chemistry and Biology. 2000, 7: 793-803. 10.1016/S1074-5521(00)00025-9
Schultz C, Link A, Leost M, Zaharevitz DW, Gussio R, Sausville EA, Meijer L, Kunick C: Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity. J Med Chem. 1999, 42 (15): 2909-2919. 10.1021/jm9900570
Zaharevitz DW, Gussio R, Leost M, Senderowicz AM, Lahusen T, Kunick C, Meijer L, Sausville EA: Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. Cancer Res. 1999, 59 (11): 2566-2569.
Leclerc S, Garnier M, Hoessel R, Marko D, Bibb JA, Snyder GL, Greengard P, Biernat J, Wu YZ, Mandelkow EM: Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?. J Biol Chem. 2001, 276 (1): 251-260. 10.1074/jbc.M002466200
Bain J, McLauchlan H, Elliott M, Cohen P: The specificities of protein kinase inhibitors; an update. Biochem J. 2003, 371: 199-204. 10.1042/BJ20021535
Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T: Selective GSK-3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes. 2003, 52 (3): 588-595.
Cohen P, Goedert M: GSK-3 inhibitors: Development and potential for the treatment of disease. Nat Rev Drug Disc. 2004
Hall RK, Yamasaki T, Kucera T, Waltner-Law M, O'Brien RM, Granner DK: Regulation of Phosphoenolpyruvate Carboxykinase and Insulin-like Growth Factor-binding Protein-1 Gene Expression by Insulin. J Biol Chem. 2000, 275: 30169-30175. 10.1074/jbc.M004898200
Nitsch D, Boshart M, Schutz G: Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements. Proc Natl Acad Sci. 1993, 90: 5479-5483.
Beurton F, Bandyopadhyay U, Dieumegard B, Barouki R, Aggerbeck M: Delineation of the insulin-responsive sequence in the rat aspartate aminotransferase gene: binding sites for HNF3 and NF-I. Biochem J. 1999, 343: 687-695. 10.1042/0264-6021:3430687
Zhang J, Ou J, Bashmakov Y, Horton JD, Brown MS, Goldstein JL: Insulin inhibits transcription of IRS-2 gene in rat liver through an insulin response element (IRE) that resembles IREs of other insulin-repressed genes. Proc Natl Acad Sci. 2001, 98 (7): 3756-3761. 10.1073/pnas.071054598
Nadal A, Marrero PF, Haro D: Down-regulation of mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase gene by insulin. Role of the forkhead transcription factor FKHRL1. Biochem J. 2002, 366 (2): 289-297.
Barthel A, Schmoll D, Kruger KD, Bahrenberg G, Walther R, Roth RA, Joost HG: Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells. Biochem Biophys Res Commun. 2001, 285 (4): 897-902. 10.1006/bbrc.2001.5261
Frame S, Cohen P: GSK3 takes centre stage more than 20 years after its discovery. Biochem J. 2001, 359: 1-16. 10.1042/0264-6021:3590001
Liu C, Li Y, Semenov M, Han C, Baeg G-H, Tan Y, Zhang Z, Lin X, He X: Control of b-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 2002, 108: 837-847. 10.1016/S0092-8674(02)00685-2
Amit S, Hatzubai A, Birman Y, Anderson JS, Ben-Shushan E, Mann M, Ben-Neriah Y, Alkalay I: Axin-mediated CKI phosphorylation of b-catenin at Ser-45: a molecular switch for the wnt pathway. Genes Dev. 2002, 16: 1066-1076. 10.1101/gad.230302
Nikolakaki E, Coffer PJ, Hemelsoet R, Woodgett JR, Defize LHK: GSK3 phosphorylates jun family members in vitro and negatively regulates their transactivating potential in intact cells. Oncogene. 1993, 8: 833-840.
Morton S, Davis RJ, McLaren A, Cohen P: A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 2003, 22 (15): 3876-3886. 10.1093/emboj/cdg388
Rogatsky I, Waase CLM, Garabedian MJ: Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activity by GSK-3. J Biol Chem. 1998, 273 (23): 14315-14321. 10.1074/jbc.273.23.14315
Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR: Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 2000, 14: 2501-2514. 10.1101/gad.836800
Fiol CJ, Williams JS, Chou CH, Wang QM, Roach PJ, Andrisani OM: A secondary phopshorylation of CREB at Ser-129 is required for the cAMP-mediated control of gene expression. A role for GSK3 in the control of gene expression. J Biol Chem. 1994, 269: 32187-32193.
Grimes CA, Jope RS: CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem. 2001, 78 (6): 1219-12132. 10.1046/j.1471-4159.2001.00495.x
Ross SE, Erickson RL, Hemati N, MacDougald OA: GSK3 is an insulin-regulated C/EBPalpha kinase. Mol Cell Biol. 1999, 19 (12): 8433-8441.
Guo S, Cichy SB, He X, Yang Q, Ragland M, Ghosh AK, Johnson PF, Unterman TG: Insulin suppresses transactivation by C/EBPbeta: Signaling to p300/CBP by protein kinase B disrupts interaction with the major activation domain of C/EBPbeta. J Biol Chem. 2001, 276: 8516-8523. 10.1074/jbc.M008542200
Duong DT, Waltner-Law ME, Sears R, Sealy L, Granner DK: Insulin inhibits hepatocellular glucose production by utilizing LIP to disrupt the association of CBP and RNA polymerase II with the PEPCK gene promoter. J Biol Chem. 2002, 277 (35): 32234-32242. 10.1074/jbc.M204873200
Tabata I, Schluter J, Gulve EA, Holloszy JO: Lithium increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes. 1994, 43 (7): 903-907.
Chen X, McMahon EG, Gulve EA: Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP1. Am J Physiol. 1998, 275 (2): E272-E277.
Orena SJ, Torchia AJ, Garofalo RS: Inhibition of GSK3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes. J Biol Chem. 2000, 275 (21): 15765-15772. 10.1074/jbc.M910002199
Henriksen EJ, Kinnick TR, Teachey MK, O'Keefe MP, Ring D, Johnson KW, Harrison SD: Modulation of Muscle Insulin Resistance by Selective Inhibition of Glycogen Synthase Kinase-3 in Zucker Diabetic Fatty Rats. Am J Physiol Endocrinol Metab. 2003, 285 (1): E98-E105.
Nikoulina SE, Ciaraldi TP, Mudaliar S, Carter L, Johnson K, Henry RR: Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes. 2002, 51 (7): 2190-2198.
Cline GW, Johnson K, Regittnig W, Perret P, Tozzo E, Xiao L, Damico C, Shulman GI: Effects of a novel GSK3 inhibitor on insulin stimulated glucose metabolism in ZDF (fa/fa) rats. Diabetes. 2002, 51: 2903-2910.
Hoeflich KP, Luo J, Rubie EA, Tsao M-S, Jin O, Woodgett JR: Requirement for GSK3beta in cell surival and NFkB activation. Nature. 2000, 406: 86-90. 10.1038/35017574
Salinas PC, Hall AC: Lithium and synaptic plasticity. Bipolar Disord. 1999, 1 (2): 87-90. 10.1034/j.1399-5618.1999.010205.x
Jimenez-Vasquez PA, Overstreet DH, Mathe AA: Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects ofelectroconvulsive stimuli. JOURNAL OF PSYCHIATRIC RESEARCH. 2000, 34 (6): 405-412. 10.1016/S0022-3956(00)00036-4
Mattson MP: Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol. 2000, 1 (2): 120-129. 10.1038/35040009
Cross DAE, Culbert AA, Chalmers KA, Facci L, Skaper SD, Reith AD: Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J Neurochem. 2001, 77 (1): 94-102.
Davis ST, Benson BG, Bramson HN, Chapman DE, Dickerson SH, Dold KM, Eberwein DJ, Edelstein M, Frye SV, Gampe RT: Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science. 2001, 291: 134-137. 10.1126/science.291.5501.134
Goff DA, Harrison DS, Nuss JM, Ring D: Inhibitors of GSK-3. US PAT. 2002, 6: 147-185.
Forest CD, O'Brien RM, Lucas PC, Magnuson MA, Granner DK: Regulation of PEPCK gene expression by insulin. Use of the stable transfection approach to locate an insulin responsive sequence. Molecular Endocrinology. 1990, 4 (9): 1302-1310.